Seeking AlphaMon, 22 Jun 2026 18:12:08 GMTEledon Pharmaceuticals, Inc. (ELDN) Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation TranscriptELDN-3.54%
Zacks Investment ResearchTue, 16 Jun 2026 14:41:03 GMTIs Eledon Pharmaceuticals (ELDN) Outperforming Other Medical Stocks This Year?ELDN-3.54%